Making history! We're proud to be the first Korean pharmaceutical company to list on NASDAQ and looking forward to embarking on phase 3 clinical trial of PM-012 for the treatment of dementia and Alzheimer’s disease with the FDA. Our goal is to make sure

by 4alzheimers · 3 years ago · via Instagram

Those suffering from Alzheimer's and dementia have been hit exceptionally hard during the COVID-19 pandemic, with deaths up over 16% nationwide in the United States. www.mediforum.co #dementiastatistics #alzheimersstatistics #covid19 #covid19stats #biot

by 4alzheimers · 5 years ago · via Instagram

Aducanumab, the latest drug approved by the FDA for the treatment of Alzheimer'sis estimated to cost $56,000 annually. According to the New York Times, "There’s little evidence that the drug, Aduhelm, slows the progression of dementia, but the Food and Dr

by 4alzheimers · 4 years ago · via Instagram

Brain One is a naturally derived supplement made from a combination of extracts to improve memory %26 concentration. Combining the natural compounds with four-year-aged Korean ginseng boosts the immune system, enhances platelet count, and increases blood

by 4alzheimers · 4 years ago · via Instagram